Efficacy and Safety of a Single Dose of Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

被引：0

作者：

Frangoul, Haydar ^{[1
]}

Locatelli, Franco ^{[2
]}

Corbacioglu, Selim ^{[3
]}

De La Fuente, Josu ^{[4
]}

Wall, Donna ^{[5
]}

Cappellini, Maria Domenica ^{[6
]}

de Montalembert, Mariane ^{[7
]}

Kattamis, Antonis ^{[8
]}

Lobitz, Stephan ^{[9
]}

Rondelli, Damiano ^{[10
]}

Sheth, Sujit ^{[11
]}

Steinberg, Martin ^{[12
]}

Walters, Mark ^{[13
]}

Bobruff, Yael ^{[14
]}

Simard, Chris ^{[14
]}

Song, Yang ^{[14
]}

Zhang, Lanju ^{[14
]}

Sharma, Anjali ^{[15
]}

Imren, Suzan ^{[14
]}

Hobbs, Bill ^{[14
]}

Grupp, Stephan A. ^{[16
]}

机构：

[1] Childrens Hosp TriStar Centennial, Nashville, TN USA

[2] Uni Rome, Rome, Italy

[3] Uni Regensburg, Regensburg, Germany

[4] Imperial Coll London, St Albans, England

[5] Hosp Sick Children, Toronto, ON, Canada

[6] Uni Milan, Milan, Italy

[7] Uni Paris, Paris, France

[8] Uni Athens, Athens, Greece

[9] Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany

[10] Uni Ill Chicago, Chicago, IL USA

[11] Weill Cornell Med, New York, NY USA

[12] BU Sch Med, Boston, MA USA

[13] UCSF Benioff Childrens Hosp, Oakland, CA USA

[14] Vertex Pharmaceut, Boston, MA USA

[15] CRISPR Therapeut, Cambridge, MA USA

[16] Uni Penn, Perelman Sch Med, Philadelphia, PA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：1 / 1

页数：1

共 50 条

[21] MODEL-PROJECTED CLINICAL OUTCOMES OF EXAGAMGLOGENE AUTOTEMCEL (EXA-CEL) IN PATIENTS WITH TRANSFUSION-DEPENDENT BETA-THALASSEMIA IN CANADA
Udeze, C.
Gargano, M.
Kaindl, L.
Kane, S.
Zhou, A.
Jain, S.
Lopez, A.
VALUE IN HEALTH, 2024, 27 (12) : S130 - S130
[22] BETIBEGLOGENE AUTOTEMCEL IN PEDIATRIC PTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA IN PHASE 3 TRIALS
Lal, Ashutosh
Kwiatkowski, Janet
Thompson, Alexis
Thuret, Isabelle
Thrasher, Adrian
Kulozik, Andreas
Hongeng, Suradej
Yannaki, Evangelia
Sauer, Martin
Guo, Ruiting
Colvin, Richard
Locatelli, Franco
Walters, Mark
PEDIATRIC BLOOD & CANCER, 2022, 69
[23] Clinical Outcomes of Molecular Matching in Transfusion-Dependent Patients with Sickle Cell Disease (SCD) and Thalassemia
de Macedo, Mayra Dorigan
dos Santos, Tamires Delfino
Perecin Menegati, Sheila Fatima
Pereira, Fabricio Biscaro
Gilli, Simone
Castilho, Lilian
TRANSFUSION, 2017, 57 : 137A - 138A
[24] The effectiveness and value of betibeglogene autotemcel for the management of transfusion-dependent beta-thalassemia
Lancaster, Victoria
Richardson, Marina
Beaudoin, Francesca L.
Synnott, Patricia G.
Rind, David M.
Herce-Hagiwara, Belen
Campbell, Jon
Pearson, Steven
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (11) : 1316 - 1320
[25] Early safety and efficacy results with a single dose of autologous CRISPR-Cas9-modified CD34+hematopoietic stem and progenitor cells in transfusion-dependent β-thalassemia and sickle cell disease
de la Fuente, Josu
Frangoul, Haydar
Bobruff, Yael
Cappellini, Maria Domenica
Corbacioglu, Selim
Fernandez, Christine Marie
Grupp, Stephan
Handgretinger, Rupert
Ho, Tony W.
Imren, Suzan
Kattamis, Antonis
Lekstrom-Himes, Julie
Locatelli, Franco
Lu, Yimeng
Mapara, Markus
Mulcahey, Sarah
de Montalembert, Mariane
Rondelli, Damiano
Shanbhag, Niraj
Sheth, Sujit
Soni, Sandeep
Steinberg, Martin H.
Weinstein, Michael
Wu, John
Wall, Donna
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 22 - 23
[26] Elimination of vaso-occlusive crises after exagamglogene autotemcel in patients with severe Sickle Cell Disease
Meisel, R.
Frangoul, H.
Locatelli, F.
Sharma, A.
Bhatia, M.
Molinari, L.
Wall, D.
Liem, R.
Telfer, P.
Shah, A.
Cavazzana, M.
Corbacioglu, S.
Rondelli, D.
Dedeken, L.
Lobitz, S.
de Montalembert, M.
Steinberg, M.
Walters, M.
Imren, S.
Shi, D.
Bower, L.
Simard, C.
Zhang, L.
Morrow, P. K.
Hobbs, B.
Grupp, S.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 99 - 100
[27] Safety of Autologous Hematopoietic Stem Cell Transplantation with Gene Addition Therapy for Transfusion-Dependent β-Thalassemia, Sickle Cell Disease, and Cerebral Adrenoleukodystrophy
Walters, Mark C.
Locatelli, Franco
Thrasher, Adrian J.
Tisdale, John F.
Orchard, Paul J.
Duncan, Christine N.
Kuehl, Joern-Sven
De Oliveira, Satiro Nakamura
Sauer, Martin G.
Kulozik, Andreas E.
Yannaki, Evangelia
Hongeng, Suradej
Mapara, Markus Y.
Krishnamurti, Lakshmanan
Hermine, Olivier
Blanche, Stephane
Aubourg, Patrick
Smith, Nicholas J. C.
Shi, Weiliang
Colvin, Richard A.
McNeil, Elizabeth
Ribeil, Jean-Antoine
Cavazzana, Marina
Williams, David A.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S38 - S39
[28] Improvements in Health-Related Quality of Life after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease
Sharma, Akshay
Frangoul, Haydar
Mapara, Markus
Imren, Suzan
Li, Nanxin
Liu, Tina
Rubin, Jaime
Shi, Daoyuan
Hobbs, William
Grupp, Stephan
BLOOD, 2023, 142
[29] Safety of Autologous Hematopoietic Stem Cell Transplantation with Gene Addition Therapy for Transfusion-Dependent β-Thalassemia, Sickle Cell Disease, and Cerebral Adrenoleukodystrophy
Yannaki, Evangelia
Locatelli, Franco
Thrasher, Adrian J.
Tisdale, John F.
Orchard, Paul J.
Duncan, Christine N.
Kuehl, Joern-Sven
De Oliveira, Satiro
Sauer, Martin G.
Kulozik, Andreas E.
Hongeng, Suradej
Mapara, Markus Y.
Krishnamurti, Lakshmanan
Hermine, Olivier
Blanche, Stephane
Aubourg, Patrick
Smith, Nicholas
Shi, Weiliang
Colvin, Richard A.
McNeil, Elizabeth
Ribeil, Jean-Antoine
Cavazzana, Marina
Walters, Mark C.
Williams, David A.
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 75 - 76
[30] HLA identical related cord blood transplantation for patients with transfusion-dependent thalassemia and sickle cell disease
Rocha, V.
Volt, F.
Ruggeri, A.
Zecca, M.
de la Tour, R. Peffault
Lewalle, P.
Dalle, J. -H.
de la Fuente, J.
Kitra-Roussou, V.
Kupesiz, A.
Poire, X.
Ghavamzadeh, A.
Yesilipek, A.
Lioure, B.
Arcese, W.
Kansoy, S.
Bertrand, Y.
Capelli, B.
Locatelli, F.
Corbacioglu, S.
Gluckman, E.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 50 - 50

← 1 2 3 4 5 →